CONDOL01: Evaluation on the Experience of Bereavement, of a Medical Consultation, Proposed by a Letter of CONDOLence to the Patients' Relatives Versus Standard Practice After the Death of the Patient
NCT ID: NCT02861625
Last Updated: 2020-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
432 participants
OBSERVATIONAL
2018-05-24
2022-06-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bereavement Management - Description, Assessment and Care
NCT01292512
Compassion Pilot Intervention Study to Enhanced Integrated Care for People With Severe Memory Problems
NCT02840318
Developing and Implementing Meaningful Activities Facilitators in Geriatric Short Stay
NCT06080126
Group Therapy For Dementia Caregivers At Risk For Complicated Grief
NCT03177772
Palliative and End-of-life Care in Advanced Dementia: Evaluation of a Program of Organization of Care in Long-term Care
NCT01441726
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
letter of condolence offering to the reliable person a post-death consultation with the reference physician (sent between J15 and J30 post death)
Letter of condolence and post-death medical consultation
Process of sending a letter of condolence with consultation proposition.
Group B
no intervention, i.e without a letter of condolence proposing a consultation with the reference physician
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Letter of condolence and post-death medical consultation
Process of sending a letter of condolence with consultation proposition.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient for which the reliable person has been identified
* Acceptation of the reference physician to send a letter of condolence with the proposed consultation
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Paoli-Calmettes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gwenaelle Gravis, MS
Role: PRINCIPAL_INVESTIGATOR
Institut Paoli-Calmettes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Paoli Calmettes
Marseille, Bouches Du Rhone, France
GRAVIS
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
GRAVIS Gwenaëlle, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CONDOL01-IPC 2015-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.